That's a Wrap on ESHRE 2025 in Paris, France

A huge thank you to everyone who attended our presentation and stopped by the Evident Microscopy booth at ESHRE 2025. We were blown away by the interest, the thoughtful questions, and the incredible turnout.

It was a proud moment for our team to share our latest clinical results from our clinical partners at IVF Australia, publicly, including pregnancies and a live birth enabled by our AI platform. We're driven by clinical impact, and seeing that resonate with so many of you reinforced exactly why we do this work.

Our Chief Scientific Officer, Dale Goss, presented preliminary clinical data of SpermSearch.AI to the ESHRE community, with live demonstrations running throughout the conference at the Evident Microscopy booth. We’d like to thank Evident for their support and confidence in displaying new and innovative technologies compatible with their high quality microscopes. The conversations we had with embryologists, clinicians, and researchers from around the world gave us valuable perspective on where the field is heading and how our technology fits into real clinical workflows.

Now it's back to business: building on the momentum, expanding our clinical data, and continuing to innovate to give patients and clinics the very best in fertility technology.

If you'd like to learn more about what we're doing at NeoGenix, from AI-powered sperm identification to next-generation sperm selection devices, get in touch. We'd love to connect.

Big thanks to the ESHRE organisers for an outstanding event and the opportunity to share our work with the global ART community.

Previous
Previous

NeoGenix paper named runner-up for the 2025 Robert G. Edwards Prize Paper